Outcomes of Limited Postoperative Restrictions Following Sling Placement: A Randomized Controlled Trial
Launched by UNIVERSITY OF IOWA · Feb 17, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best way to help women recover after surgery for stress urinary incontinence, which is a condition that causes unintentional leakage of urine during activities like coughing, sneezing, or exercising. The trial will compare two groups of women who are undergoing a procedure called a midurethral sling placement. One group will follow standard recovery guidelines, which include avoiding moderate activities and not lifting anything heavier than 15 pounds for six weeks after surgery. The other group will have fewer restrictions and can return to their normal activities and lifting without limits right after the surgery.
Women aged 36 to 75 who are having this specific surgery may be eligible to participate in the trial. Throughout the study, participants will fill out surveys at 2 weeks, 3 months, and 1 year after their surgery to share how they are feeling and whether they followed the recovery guidelines. This information will help doctors understand if the level of activity restriction after surgery makes a difference in recovery and overall outcomes. If you're considering this procedure and are interested in participating, it could be a great way to contribute to important research while also receiving care.
Gender
FEMALE
Eligibility criteria
- • Inclusion: Undergoing isolated synthetic mesh retropubic midurethral sling placement Exclusion criteria: Non-English speaking, incarcerated, cognitive impairment precluding informed consent, unable to ambulate without the assistance of an ambulation device, concurrent prolapse procedure
About University Of Iowa
The University of Iowa, a leading academic and research institution, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses the expertise of its faculty and researchers to investigate cutting-edge therapies and treatments across various medical fields. Committed to ethical research practices and patient-centered care, the University of Iowa strives to contribute significantly to medical knowledge and improve health outcomes through rigorous scientific inquiry and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Iowa City, Iowa, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported